English | Español
Press release submission | Sep 27, 2018

MONTEFIORE HEALTH SYSTEM: Montefiore Earns Highest Status in Stroke Care
Press release submission | Sep 27, 2018

ABBOTT CORPORATION: Receives CE Mark for First Troponin Test to Help Predict the Chance of Heart Attack in Apparently Healthy Adults Potentially Months to Years in Advance
Press release submission | Sep 23, 2018

ABBVIE: Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
Press release submission | Sep 23, 2018

ELI LILLY AND COMPANY: Lilly Receives Positive CHMP Opinion for Emgality™ (galcanezumab) for the Prophylaxis of Migraine in Adults
Press release submission | Sep 16, 2018

GENENTECH INC: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
Press release submission | Sep 16, 2018

ASTRAZENECA: US FDA approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for certain patients with relapsed or refractory hairy cell leukemia

Press release submission | Sep 5, 2018

LIVONGO HEALTH: Becomes First Comprehensive Diabetes Offering to Add Abbott’s FreeStyle® Libre Pro System to Platform
Press release submission | Sep 5, 2018

NUVASIVE INC: To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

Baylor College of Medicine partners with Site Tx on immune-targeted drug discovery